Skip to Content Facebook Feature Image

VENU's $1.5 Billion Development Pipeline Highlighted in VenuesNow Cover Story on National Amphitheater Boom

Business

VENU's $1.5 Billion Development Pipeline Highlighted in VenuesNow Cover Story on National Amphitheater Boom
Business

Business

VENU's $1.5 Billion Development Pipeline Highlighted in VenuesNow Cover Story on National Amphitheater Boom

2026-07-08 19:04 Last Updated At:19:30

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Jul 8, 2026--

Venu Holding Corporation ("VENU" or the "Company") (NYSE AMERICAN: VENU), an owner, operator, and developer of premium live entertainment destinations, today announced that it was prominently featured in a recent VenuesNow cover story examining the strongest amphitheater development cycle in recent U.S. history.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708232259/en/

The article, written by Wendy Pearl, surveys the national landscape of new and redeveloped amphitheaters and identifies VENU as a company setting a new standard for the category. The piece notes that VENU's current slate of five active projects represents approximately $1.5 billion in development, spanning its flagship award-winning Ford Amphitheater in Colorado Springs, Regent Bank Amphitheater in Broken Arrow, Oklahoma, Sunset Amphitheater in McKinney, Texas, and venues under development in El Paso and Webster, Texas, and Chattanooga, Tennessee.

"Most of the outdoor venues fans grew up on were built for a different era of live entertainment," said J.W. Roth, Founder, Chairman, and CEO of VENU. "We're not building amphitheaters in the traditional sense. We're building venues that can operate multi-seasonally on a more-than-music model and become anchors for the communities around them."

The article describes VENU's approach as building "next-generation" venues designed to operate year-round rather than for a traditional limited concert season, a distinction central to the Company's development strategy and omni-content programming model. Municipal participation, through assistance such as contributed real estate and tax incentives, has become a backbone of that strategy, underpinning VENU's rapid expansion across the country.

About Venu Holding Corporation

Venu Holding Corporation ("VENU") (NYSE American: VENU) is a premier owner, developer, and operator of luxury, experience-driven entertainment destinations. Founded by Colorado Springs entrepreneur J.W. Roth, VENU has a portfolio of premium brands that includes Ford Amphitheater, Sunset Amphitheaters, Phil Long Music Hall, The Hall at Bourbon Brothers, Bourbon Brothers Smokehouse and Tavern, Aikman Owners Clubs, and Roth’s Sea & Steak. With venues operating and in development across Colorado, Georgia, Oklahoma, Tennessee, and Texas and a nationwide expansion underway, VENU is setting a new standard for live entertainment.

VENU has been recognized nationally by The Wall Street Journal, The New York Times, Billboard, VenuesNow, and Variety for its innovative and disruptive approach to live entertainment. Through strategic partnerships with industry leaders such as AEG Presents, NFL Hall of Famer and Founder of EIGHT Elite Light Beer, Troy Aikman, Billboard, Aramark Sports + Entertainment, Tixr, Boston Common Golf, Niall Horan, and Dierks Bentley, VENU continues to shape the future of the entertainment landscape. For more information, visit VENU’s website, Instagram, LinkedIn, or X.

Forward Looking Statements

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on the Company’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the sections titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, on file with the SEC, as well as in reports subsequently filed by the Company with the SEC. Forward-looking statements contained in this announcement and in the investor Q&A with Shah Gilani, are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

VENU's Ford Amphitheater in Colorado Springs, CO

VENU's Ford Amphitheater in Colorado Springs, CO

加州,聖馬提歐--(BUSINESS WIRE)--七月 9, 2026--

(美國商業資訊)-- 《精神分裂症公報》(Schizophrenia Bulletin) 今天發表了一份開創性的隨機對照試驗 (RCT) 報告。越來越多研究探討應用生酮飲食治療精神病性障礙的潛在效益,這項由加州大學舊金山分校 (UCSF) 的研究人員進行、並獲美國國家心理健康研究所 (NIMH) 贊助部分資金的試驗為這類研究報告增添一筆新發現。這項研究徵求患有精神分裂症譜系障礙或I型躁鬱症的受試者進行為期一個月的開放標籤階段初始隨機對照試驗。結果顯示,與一般飲食相比,生酮飲食能迅速改善代謝狀況。此外,某些受試者繼續進行為期四個月的生酮飲食單臂研究,他們的代謝、精神狀況及認知功能指標均呈現顯著改善。

本新聞稿包含多媒體資訊。完整新聞稿請見此: https://www.businesswire.com/news/home/20260618646955/zh-HK/

在錄取的58名受試者中,47人完成了為期一個月的初步生酮飲食與一般飲食效果對照研究。其中25名受試者選擇繼續攝取生酮飲食,將試驗總時長延長至四個月(即單臂延長研究)。研究結果顯示生酮飲食具有高度可行性:在為期一個月的隨機對照試驗中,83%接受每日檢測的受試者維持生酮狀態;在延長至四個月的試驗中,這一比例達到94%;而且沒有人表示因採取生酮飲食而引起嚴重副作用。

採取生酮飲食的受試者在一個月後與對照組相比,其關鍵代謝指標顯示出具統計意義的改善。在這項對照試驗中,即便排除了體重減輕的影響,較高的酮體數值仍與血糖降低及憂鬱症狀 (PHQ-9) 減輕相關。這表明所觀察到的效應可歸因於生酮狀態本身,而不只是體重減輕的結果。

為期四個月的延長研究則顯示受試者不僅代謝狀況持續改善,憂鬱和精神分裂症症狀也顯著減輕,認知功能也有所增強。儘管這項單臂延長研究的受試者僅有25名,但它釋放出生酮飲食有希望成為治療嚴重精神疾病的介入手段,仍足以鼓舞人心。

「我們觀察到認知和心理症狀方面的改善。這對精神病性障礙患者尤其重要,因為現有的抗精神病藥物雖然能夠緩解精神病症狀,卻無法改善患者包括認知或憂鬱症狀的整體心理健康,然而這些症狀往往嚴重衝擊患者的生活。」研究負責人、加州大學舊金山分校 (UCSF) 及威爾神經科學研究所 (Weill Institute for Neurosciences)精神科教授Judith M. Ford博士說。Ford教授指出,儘管研究結果令人振奮,但也表明有必要進行更大規模、更長期且全面控管的對照試驗,以驗證這些益處在大規模應用中是否依然成立。

該研究報告的作者群強調,一個月的介入似乎不足以反映這種介入辦法潛在的心理健康治療益處,而四個月研究觀察到的顯著認知和精神改善有必要在控管嚴謹的狀態下進行再驗證。這些結果與最近的幾項 精神分裂症 與 躁鬱症 試行研究結果一致。這些結果共同表明進行更大規模、更長期隨機對照試驗的必要,才能評估應用生酮療法治療嚴重精神疾病患者的效果與安全性。

「這項研究提供進一步證明,指出生酮療法是一種可行、安全的嚴重精神疾病治療方案,而且有潛力帶來變革性療效。」贊助該研究的Baszucki Group聯合創始人兼總裁Jan Ellison Baszucki表示,「現在我們應該以多元且持續的方式投入精神疾病代謝療法研究,進行嚴謹的科學檢證,以擴大這些研究的範圍,並提高群眾對其潛力的認識。」

關於Baszucki Group

Baszucki Group 由Roblox創辦人兼執行長David Baszucki和暢銷書作家Jan Ellison Baszucki創立於2021年。該集團利用私人捐贈、影響力投資、宣傳宣導、故事講述和社群建構等方式在科學、醫學、農業、食品及生態環境系統領域推動根本性變革。Baszucki Group的主要目標是透過支持代謝、精神病學和神經科學交叉領域的研究活動來改善心理健康。如欲進一步瞭解精神障礙以及腦部健康的代謝治療方法,包括生酮療法,請造訪Baszucki Group的非營利性計畫 Metabolic Mind 。

免責聲明:本公告之原文版本乃官方授權版本。譯文僅供方便瞭解之用,煩請參照原文,原文版本乃唯一具法律效力之版本。

請前往 businesswire.com 瀏覽源版本:https://www.businesswire.com/news/home/20260618646955/zh-HK/

Baszucki Group媒體聯絡人:media@baszuckigroup.org

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: MENTAL HEALTH RESEARCH HOSPITALS FITNESS & NUTRITION CLINICAL TRIALS HEALTH GENERAL HEALTH OTHER SCIENCE SCIENCE

SOURCE: Baszucki Group

Copyright Business Wire 2026.

PUB: 07/09/2026 05:12 AM/DISC: 07/09/2026 05:12 AM

http://www.businesswire.com/news/home/20260618646955/zh

第一項應用隨機對照試驗探究應用生酮飲食治療精神病性障礙成效的報告顯示樂觀前景。

第一項應用隨機對照試驗探究應用生酮飲食治療精神病性障礙成效的報告顯示樂觀前景。

Recommended Articles